128 results on '"Wilson, Nicholas J."'
Search Results
2. Targeting the Human βc Receptor Inhibits Contact Dermatitis in a Transgenic Mouse Model
3. What can neuroscience offer marketing research?
4. Double‐Diffusive Layer and Meltwater Plume Effects on Ice Face Scalloping in Phase‐Change Simulations
5. Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants
6. Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
7. CSF3R/CD114 mediates infection-dependent transition to severe asthma
8. Individual differences in experience after a control task: Boredom proneness, curiosity, and grit correlate with emotion
9. Anti‐β c mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model
10. cAMP inhibits CSF-1-stimulated tyrosine phosphorylation but augments CSF-1R-mediated macrophage differentiation and ERK activation
11. IL-12 and IL-23: master regulators of innate and adaptive immunity
12. What can neuroscience offer marketing research?
13. Machine learning applied to whole-blood RNA-sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus
14. A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus
15. Anti‐βc mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model.
16. A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
17. Role of the β Common (βc) Family of Cytokines in Health and Disease
18. Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis
19. Combining multiple tools outperforms individual methods in gene set enrichment analyses
20. Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
21. A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus
22. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors
23. Reconciling the North: Transit Pipelines and the Pursuit of Self-Sufficient Self-Government in the Yukon.
24. Unexpected mechanisms of action for a cytokine receptor-blocking antibody
25. 78
26. Combining multiple tools outperforms individual methods in gene set enrichment analyses.
27. Dual Mechanism of Interleukin-3 Receptor Blockade by an Anti-Cancer Antibody
28. Identification of potent antagonist antibodies against mouse IL-13Rα1 using novel bioassays
29. Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362
30. The liberalism of fear
31. Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor α1
32. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors.
33. Confirmation of Syva enzyme multiple immunoassay technique (EMIT).
34. The Critical Role of the Colony-Stimulating Factor-1 Receptor in the Differentiation of Myeloblastic Leukemia Cells
35. Development, cytokine profile and function of human interleukin 17–producing helper T cells
36. 78: Insights into the function of an anti-leukaemia antibody: structural studies of CSL362 bound to soluble CD123
37. A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling
38. Colony-stimulating factor-1 (CSF-1) receptor-mediated macrophage differentiation in myeloid cells: a role for tyrosine 559-dependent protein phosphatase 2A (PP2A) activity
39. Proteomic Analysis of Macrophage Differentiation
40. Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells
41. Short‐chain fatty acids reduce expression of specific protein kinase C isoforms in human colonic epithelial cells
42. Expression of a Y559F Mutant CSF-1 Receptor in M1 Myeloid Cells: A Role for Src Kinases in CSF-1 Receptor-Mediated Differentiation
43. Roles of the Mitogen-activated Protein Kinase Family in Macrophage Responses to Colony Stimulating Factor-1 Addition and Withdrawal
44. Protein phosphatase 2A is expressed in response to colony-stimulating factor 1 in macrophages and is required for cell cycle progression independently of extracellular signal-regulated protein kinase activity
45. cAMP Enhances CSF-1-Induced ERK Activity and c-fosmRNA Expression via a MEK-Dependent and Ras-Independent Mechanism in Macrophages
46. Machine learning applied to whole‐blood RNA‐sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus.
47. Targeting the human βcreceptor inhibits contact dermatitis in a transgenic mouse model
48. Anti‐β c mAb CSL311 inhibits human nasal polyp pathophysiology in a humanized mouse xenograft model
49. A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
50. Unexpected mechanisms of action for a cytokine receptor-blocking antibody
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.